Here, we show that LGR5 is highly expressed in a subset of NB tumors and cell lines and that anti-LGR5 ADC with a PBD payload is highly effective in inhibiting the growth NB cells with a high LGR5 expression in vitro and in vivo. This evidence concerns the gene LGR5 and neuroblastoma.